Clinical trials: Sellar and Suprasellar Masses
Craniopharyngiomas, Pituitary Macroadenoma
Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors
Craniopharyngiomas and giant invasive pituitary adenomas, with lesions originating from the pituitary stalk, are frequently associated with intraoperative and postoperative diabetes insipidus (DI).
- Conditions
- Craniopharyngiomas, Pituitary Macroadenoma, Sellar and Suprasellar Masses
- Trial name
- RCT-PIDST (NCT07712328)
- Testing
- Desmopressin (DDAVP), Control
- Where
- China
- Volunteers
- 152 people
- Sponsor
- Zhaoyun Zhang
Sellar and Suprasellar Masses, Pituitary Tumor
Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery
1. Access the optimal cut point value of copeptin which predicts development of central diabetes insipidus postoperatively with highest accuracy. 2.
- Trial name
- NCT04369703
- Where
- United States
- Volunteers
- 199 people
- Sponsor
- Mayo Clinic